| Literature DB >> 33001042 |
Hicaz Zencirkiran Agus1, Gamze Babur Guler1, Mehmet Ali Astarcioglu2, Ahmet Guner1, Ismail Gurbak1, Oya Atamaner1, Anil Sahin1, Ahmet Yasar Cizgici1, Alev Kilicgedik3.
Abstract
OBJECTIVE: This prospective study aimed to investigate the myocardial energy metabolism in severe mitral regurgitation (MR) and explore its effect on postoperative differentiation of ejection fraction (EF).Entities:
Mesh:
Year: 2020 PMID: 33001042 PMCID: PMC7585961 DOI: 10.14744/AnatolJCardiol.2020.03835
Source DB: PubMed Journal: Anatol J Cardiol ISSN: 2149-2263 Impact factor: 1.596
Figure 1(a) Parasternal long-axis view of transthoracic echocardiography. MEE can be calculated by the formula explained in the text. PWT (marked with asterisk), LV diameters, ejection time, LVOT diameter, LVOT, and VTI are needed for the calculation. (b) Ejection time and LVOT VTI (pulsed Doppler of left ventricular outflow track and trace of velocity time integral) are shown
LV - left ventricle; LVOT - left ventricular outflow tract; MEE - myocardial energy expenditure; PWT - posterior wall thickness; VTI - velocity time integral
Univariate analysis using Spearman’s correlation coefficients between preoperative ejection fraction and some specific variables
| Preop EF | 1.000 | ||||||||
| Age | -.166 | 1.000 | |||||||
| .129 | . | ||||||||
| NT-proBNP | -.461 | .325 | 1.000 | ||||||
| .003 | . | ||||||||
| LA | -.126 | .013 | .152 | 1.000 | |||||
| .251 | .907 | .167 | . | ||||||
| ERO | .277 | -.209 | -.207 | .415 | .242 | 1.000 | |||
| .055 | .059 | .000 | .025 | . | |||||
| ESS | -.532 | -.130 | .166 | .241 | .154 | -.088 | 1.000 | ||
| .236 | .132 | .026 | .159 | .421 | . | ||||
| MEEs | -.345 | -.173 | -.163 | -.032 | -.121 | -.088 | .680 | 1.000 | |
| .112 | .138 | .770 | .271 | .422 | .000 | . | |||
| MEEm | -.352 | -.245 | -.056 | .034 | -.045 | -.114 | .739 | .908 | 1.000 |
| .024 | .611 | .759 | .680 | .297 | .000 | .000 | . | ||
P values reported under correlation coefficients.
Denotes a significance level of 0.05 or less
EF - ejection fraction; ERO - effective regurgitant orifice; ESS - circumferential end-systolic stress; LA - left atrium; MEEm - myocardial energy expenditure per minute; MEEs - myocardial energy expenditure per systole; NT-proBNP - N-terminal pro-brain natriuretic peptide
Comparison of clinical and laboratory characteristics between patients with reduced and nonreduced postoperative ejection fraction
| Gender (male) (%) | 13 (54.2) | 12 (50) | 1.0 |
| Diabetes mellitus (%) | 5 (20) | 9 (37.5) | 0.217 |
| Hypertension (%) | 17 (68) | 11 (45.8) | 0.154 |
| Smoking (%) | 4 (16) | 3 (12.5) | 1.0 |
| NYHA class (2<) (%) | 10 (40) | 15 (62.5) | 0.156 |
| Etiology | |||
| RHD | 6 (24) | 6 (25) | |
| Degenerative | 9 (36) | 13 (54.2) | 0.305 |
| Functional | 10 (40) | 5 (20.8) | |
| Age | 59±10 | 59±16 | 0.978 |
| BMI | 29±5 | 28±5 | 0.787 |
| Hgb (g/L) | 12.3±1.9 | 12.7±1.8 | 0.482 |
| Creatinine (mg/dL) | 0.88±0.20 | 0.85±0.17 | 0.646 |
| NT-proBNP | 483 (95-1314) | 1161 (494-2325) | |
| SBP | 126±15 | 127±18 | 0.743 |
| DBP | 75 (70-88) | 81 (70-90) | 0.107 |
| HR | 78±18 | 85±19 | 0.208 |
| Preop EF | 53 (41-63) | 60 (49-65) | 0.091 |
| LA (mm) | 42±6.5 | 47±6 | |
| ERO | 0.45±0.18 | 0.48±0.18 | 0.540 |
| SV | 61±16 | 53±15 | 0.060 |
| ET | 286±30 | 278±27 | 0.340 |
| TAPSE (mm) | 21±3.7 | 20±3 | 0.346 |
| PAPs (mm Hg) | 39±11 | 41±14 | 0.481 |
| cESS (kdyne/cm2) | 209±86 | 264±61 | |
| MEEs (cal/systole) | 1.6±0.8 | 1.69±0.75 | 0.717 |
| MEEm (cal/min) | 114 (73-139) | 146 (85-185) | 0.187 |
| Total operation time | 240 (198-296) | 240 (225-300) | 0.562 |
| CPBT (min) | 118 (107-137) | 110 (98-185) | 0.762 |
| XCT (min) | 78 (64-97) | 77 (66-114) | 0.658 |
BMI - body mass index; CPBT - cardiopulmonary bypass time; DBP - diastolic blood pressure; EF - ejection fraction; ET - ejection time; ERO - effective regurgitant orifice;
cESS - circumferential end-systolic stress; Hgb - hemoglobin; HR - heart rate; LA - left atrium; MEEm - myocardial energy expenditure per minute; MEEs - myocardial energy expenditure per systole; NT-proBNP - N-terminal pro-brain natriuretic peptide; NYHA - New York Heart Association; PAPs - pulmonary artery systolic pressure; SBP - systolic blood pressure;
SV - stroke volume; TAPSE - tricuspid annular plane systolic excursion; XCT - aortic cross-clamping time
Multiple logistic regression analysis for independent predictors of decrease in ejection fraction
| β | OR | P | 95% CI | |
|---|---|---|---|---|
| EF basal | 0.026 | 1.027 | 0.593 | 0.933-1.130 |
| LA | 0.123 | 1.131 | 0.025 | 1.016-1.259 |
| ESS | 0.014 | 1.014 | 0.047 | 1.000-1.029 |
| NT- proBNP | 0.001 | 1.001 | 0.101 | 1.000-1.001 |
Hosmer-Lemeshow test, 0.111; Nagelkerke R square, 0.424.
EF - ejection fraction; ESS - end-systolic stress; LA - left atrium; NT-proBNP - N-terminal pro-brain natriuretic peptide